Esteve, a CataloniaBio & HealthTech member, ended 2019 with the sale of its generics division and kicked off 2020 with the acquisition of German pharmaceutical company Riemser.
With its headquarters in Berlin and geographical presence in four countries (Germany, United Kingdom, France and Spain), Riemser has a diversified portfolio of products with the three main therapeutic areas being: oncology, neurology and niche therapies. Over 80% of sales come from the hospital channel.
Esteve CEO Staffan Schüberg said, "This acquisition makes Esteve much more of an international proprietary, specialty pharma company, and opens the door to the growing hospital sector."
Photo: Esteve headquarters in Barcelona - © Esteve
Comments